FDA Clearance Tracker · P880009
VIRAPAP HUMAN PAPILLOMAVIRUS DNA DETECTION KIT
Last checked: Nov 20, 2026Latest source record: Dec 23, 1988 (this decision)Source: openFDAMethods & limitations
Decided
Dec 23, 1988
Approval withdrawn
Time to decision
310 days
Received Feb 17, 1988. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P880009
- Device name
- VIRAPAP HUMAN PAPILLOMAVIRUS DNA DETECTION KIT
- Applicant
- Qiagen, Inc.
- Applicant location
- Gaithersburg, MD
- Received
- Feb 17, 1988
- Decided
- Dec 23, 1988
- Decision
- Approval withdrawn
- Supplements
- 5 in FDA's data for this PMA. See them on the FDA record
Device type
- Device class
- Class III
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code MAQ (KIT, DNA DETECTION, HUMAN PAPILLOMAVIRUS).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Qiagen, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P160052 · Decided Apr 11, 2018 · 497 days after receipt
Device type: Placental alpha microglobulin-1 immunoassay (QBB) · Laboratory Medicine & Pathology
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.